By G HossainPosted on October 31, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, including liver disease, cancer and immunology. Gilead Still Hungry for Deals as HIV Portfolio Grows, Veklury Crashes Post navigation Evommune Joins IPO Class With Planned $160M Raise for Immuno PipelineAbbVie’s Immunology Dyad Dominates Again in Q3